Thus, the roles of the ACE2/Ang-(1–7)/MasR axis in cancer are complicated, although studies have regarded ACE2 and AngII as therapeutic drugs against cancer (Gallagher et al., 2014). This evidence concerns the gene MAS1L and cancer.